Bionime Corporation (TPE:4737)

Taiwan · Delayed Price · Currency is TWD

62.70

-0.30 (-0.48%)

Apr 29, 2026, 1:30 PM CST

26.30% (1Y)

Market Cap	4.24B
Revenue (ttm)	1.84B
Net Income (ttm)	-180.28M
Shares Out	67.29M
EPS (ttm)	-2.68
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	93,668
Average Volume	248,308
Open	63.00
Previous Close	63.00
Day's Range	62.50 - 63.30
52-Week Range	49.10 - 73.90
Beta	-0.02
RSI	46.58
Earnings Date	May 8, 2026

About Bionime

Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offers blood glucose monitoring devices and systems under the RIGHTEST brand; a continuous glucose monitoring system under the iFree CGM brand; and medical blood glucose management systems. It is also involved in the prov... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2003

Employees 500

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 4737

Full Company Profile

Financial Performance

In 2025, Bionime's revenue was 1.84 billion, a decrease of -4.92% compared to the previous year's 1.93 billion. Losses were -180.28 million, 41.7% more than in 2024.

Financial Statements

News

There is no news available yet.